Huriez syndromeQ84.2

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.12.2021

Dieser Artikel auf Deutsch

Synonym(s)

Huriez syndrome; OMIM 181600; Palmoplantar keratoderma with sclerodactyly and increased risk of skin cancer; Sclerotylosis

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Huriez, 1965

DefinitionThis section has been translated automatically.

Very rare, autosomal dominantly inherited genodermatosis (7 families have been described so far) characterized by the triad:

  • Diffuse scleroatrophy of the hands with sclerodactyly and strikingly short fingers,
  • Diffuse palmoplantar keratosis...
  • Pronounced hypoplastic nails.

Of particular clinical importance is the development of aggressively growing carcinomas with a high metastatic potential in about 15% of affected patients. It is therefore assumed that there is a precancerous predisposition in Huriez syndrome.

EtiopathogenesisThis section has been translated automatically.

Autosomal dominant inherited gene defect of the skin-specific short isoform of SMARCAD1 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1) on chromosome 4 (gene locus: 4q23). SMARCAD1 plays a role in the initial step of double-strand break repair ("end resection"). This repair defect explains the predisposition of patients to develop squamous cell carcinoma at an early stage. Furthermore, it is discussed that SMARCAD1 promotes a depletion of dermal Langerhans cells.

ManifestationThis section has been translated automatically.

Congenital or manifestation within the first years of life.

Clinical featuresThis section has been translated automatically.

  • Diffuse scleratrophy of the hands occurring in both men and women; similar changes, usually not so pronounced on the feet; often there is no Raynaud's symptom. Mostly distinct sclerodactyly. The hands and feet show extensive lamellar hyperkeratosis, which is intensified at pressure points. The skin is dry overall, there is hypohidrosis. The face shows telangiectasia. The nails are hypoplastic.
  • Occasionally associations with foudroyant metastatic carcinomas of the skin have been described (Çelik NS et al. 2018). These squamous cell carcinomas develop in the 3-4 decade of life and occur in regions also characterized by sclerosis and atrophy. Patients often develop intestinal carcinomas.

HistologyThis section has been translated automatically.

Acanthosis; hypergranulose, non-specific, discrete perivascular lymphocytic infiltrate. Reduction of Langerhans cells in lesional skin.

Differential diagnosisThis section has been translated automatically.

Complication(s)This section has been translated automatically.

early (3rd-4th decade of life) development of squamous cell carcinomas in up to 15% of patients with a high risk of metastasis to lesional skin (palmoplantar).

Furthermore, the occurrence of oropharyngeal and gastric carcinomas has been described.

TherapyThis section has been translated automatically.

Regarding the underlying disease, a therapy is not known. Preventive consistent sun protection. If carcinomas occur in lesional skin (palms and soles), symptomatic therapy.

LiteratureThis section has been translated automatically.

  1. Çelik NS et al. (2018) A Rare Syndrome Resembling Scleroderma: Huriez Syndrome. Skin Appendage Disord 4:82-85.
  2. Guerriero C et al (2000) Huriez syndrome: case report with detailed analysis of skin dendritic cells. Br J Dermatol 143: 1091-1096
  3. Huriez C et al (1965) Génodermatosis scléroatrophiante et kératodermique des extrémites. Ann Dermatol Syphiligr 96: 135-146
  4. Watanabe E et al. (2003) A nonfamilial japanese case of Huriez syndrome: p 53 expression in squamous cell carcinoma. Dermatology 207: 82-84
  5. Günther C, et al. (2018) SMARCAD1 haploinsufficiency underlies Huriez syndrome and associated skin cancer susceptibility. J Invest Dermatol 138:1428-1431.

Authors

Last updated on: 29.12.2021